© 2020 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
December 21, 2018
Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.
October 17, 2018
The approval is based on data from two randomized, sham injection-controlled, double-masked phase 3 clinical trials with patient follow-up for 3 years.
October 16, 2018
Here: highlights of some of the studies that will be presented at the American College of Rheumatology 2018 Annual Meeting in Chicago from October 19 to 24.
September 28, 2016
Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.
July 07, 2016
In this story, we revisit the clinical trials that led to the approval of adalimumab for uveitis.
August 29, 2012
The tumor necrosis factor α antagonist infliximab has been used for treating patients with uveitis resistant to corticosteroids.